Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

LPC-011

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Hydroxamic AcidsThreonine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Lipid A Has Significance for Optimal Growth of Coxiella burnetii in Macrophage-Like THP-1 Cells and to a Lesser Extent in Axenic Media and Non-phagocytic Cells
Lipid A is an essential basal component of lipopolysaccharide of most Gram-negative bacteria. Inhibitors targeting LpxC, a… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011
BackgroundChlamydia species are obligate intracellular bacteria that infect a broad range of mammalian hosts. Members of related… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
OBJECTIVES Inhibitors of uridine diphosphate-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC, which catalyses… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE